Structural violence and the biomedical innovation system: what responsibility do universities have in ensuring access to health technologies?

摘要

When universities engage in inequitable technology transfer practices, by patenting and exclusively licensing biomedical innovations in ways enabling pricing monopoly formation, they contribute to harmful barriers to access to medicines and other health technologies for millions of people.